Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update
November 10, 2021 07:00 ET
|
Aadi Bioscience
FYARRO™ under review with FDA with a November 26, 2021 PDUFA target dateThree key executive appointments made to the roles of Chief Operating Officer, Chief Medical Officer and Chief Financial...
Aadi Bioscience to Participate in Upcoming Investor Conferences
November 09, 2021 08:00 ET
|
Aadi Bioscience
LOS ANGELES, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”), clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with...
Aadi Bioscience Appoints Scott Giacobello as Chief Financial Officer
November 01, 2021 16:05 ET
|
Aadi Bioscience
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer
October 25, 2021 08:00 ET
|
Aadi Bioscience
LOS ANGELES, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology
October 22, 2021 08:00 ET
|
Aadi Bioscience
LOS ANGELES, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience to Participate in H.C. Wainwright’s 2nd Annual Precision Oncology Conference 2021
October 19, 2021 17:22 ET
|
Aadi Bioscience
LOS ANGELES, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”), a privately-held clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience to Present New Preclinical Data on nab-Sirolimus (ABI-009) at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
October 06, 2021 08:00 ET
|
Aadi Bioscience
- Poster Presentation to go Live on October 7, 2021 at 9 a.m. ET and on Demand at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics - LOS ANGELES, Oct. ...
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
September 20, 2021 08:30 ET
|
Aadi Bioscience
LOS ANGELES, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience Appoints Emma Reeve to its Board of Directors
September 13, 2021 08:00 ET
|
Aadi Bioscience
LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined...
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
August 26, 2021 16:05 ET
|
Aadi Bioscience
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155 million PIPE financing is backed by leading life science investors led...